TAILORED-AF
2025
Artificial Intelligence for Individualized Treatment of Persistent Atrial Fibrillation: a Randomized Controlled Trial
In 370 patients with drug-refractory persistent atrial fibrillation, AI-guided ablation of electrogram dispersion added to pulmonary vein isolation improved freedom from atrial fibrillation at 12 months compared with pulmonary vein isolation alone.
Result
- Absolute difference
- 18 points
- NNT
- 6
Absolute difference and NNT are derived from the event rates.
Also reported: For superiority); no significant difference in freedom from any atrial arrhythmia after one procedure; safety composite did not differ; procedure and ablation times twice as long in the tailored arm.
- Subtopic
- Rhythm & devices
- Design
- Multicentre double-blind superiority RCT
- Relevance
- Important: one of several pillars.
- Source
- Deisenhofer I, et al. Nat Med. 2025;31(4):1286-1293.doi 10.1038/s41591-025-03517-w
Discussion & critique
The first randomised trial in which an AI-identified ablation target beat pulmonary vein isolation alone in persistent AF. The gain was specific to AF: freedom from any atrial arrhythmia was not different, because tailored ablation can leave organised atrial tachycardias that need a further procedure, and the procedures took twice as long. Follow-up was 12 months after a single procedure.